SPADE: Design of a real-world observational study of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (UC) in the Asia-Pacific (APAC) region.

被引：0

作者：

Su, Po-Jung

Park, Se Hoon

Tsai, Yu Chieh

Kim, Miso

Wu, Wen-Jeng

Gao, Seasea

Shin, Sang Joon

机构：

[1] Chang Gung Mem Hosp, Linkou Branch, Taoyuan, Taiwan

[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[3] Natl Taiwan Univ Hosp, Taipei, Taiwan

[4] Seoul Natl Univ Hosp, Seoul, South Korea

[5] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[6] Merck Pte Ltd, Singapore, Singapore

[7] Merck KGaA, Darmstadt, Germany

[8] Yonsei Univ, Yonsei Canc Ctr, Hlth Syst, Seoul, South Korea

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS577

引用

页数：1